CUSIP: 17240Y109
Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
29,632,635
-
Share change
-
+29,630,364
-
Total reported value
-
$519,789,579
-
Price per share
-
$17.54
-
Number of holders
-
53
-
Value change
-
+$519,749,579
-
Number of buys
-
52
Quarterly Holders Quick Answers
What is CUSIP 17240Y109?
CUSIP 17240Y109 identifies CINC - CINCOR PHARMA INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 17240Y109:
Institutional Holders of CINCOR PHARMA INC - COM (CINC) as of Q1 2022
As of 31 Mar 2022,
CINCOR PHARMA INC - COM (CINC) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,632,635 shares.
The largest 10 holders included
Sofinnova Investments, Inc., 5AM Venture Management, LLC, GENERAL ATLANTIC, L.P., PERCEPTIVE ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., venBio Partners LLC, BVF INC/IL, RTW INVESTMENTS, LP, Rock Springs Capital Management LP, and Omega Fund Management, LLC.
This page lists
53
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.